Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathie Beland

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Hepatology (Baltimore, Md.)|October 18, 2015
ReplyKathie Beland, Fernando Alvarez
Molecular Therapy. Advances|May 15, 2026
Modulating viscosity improves lentiviral transduction of NK cells: A simple solution to a persistent problemMila Bjelica, Aissa Benyoucef, Hugo Romero, et al.
Autoimmunity|October 23, 2004
Anti-soluble liver antigen (SLA) antibodies in chronic HCV infectionSusana Vitozzi, Pascal Lapierre, Idriss Djilali-Saiah, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|July 18, 2012
Predictive factors of lamivudine treatment success in an hepatitis B virus-infected pediatric cohort: a 10-year studyYasmine Yousef, Kathie Beland, Emmanuel Mas, et al.
Seminars in Hematology|December 1, 2020
Genetic and epigenetic modification of human primary NK cells for enhanced antitumor activityMeisam Naeimi Kararoudi, Brian P Tullius, Nitin Chakravarti, et al.
Hepatology (Baltimore, Md.)|July 18, 2015
A novel "humanized mouse" model for autoimmune hepatitis and the association of gut microbiota with liver inflammationMuhammed Yuksel, Yipeng Wang, Ningwen Tai, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Hepatology (Baltimore, Md.)|October 18, 2015
ReplyKathie Beland, Fernando Alvarez
Molecular Therapy. Advances|May 15, 2026
Modulating viscosity improves lentiviral transduction of NK cells: A simple solution to a persistent problemMila Bjelica, Aissa Benyoucef, Hugo Romero, et al.
Autoimmunity|October 23, 2004
Anti-soluble liver antigen (SLA) antibodies in chronic HCV infectionSusana Vitozzi, Pascal Lapierre, Idriss Djilali-Saiah, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|July 18, 2012
Predictive factors of lamivudine treatment success in an hepatitis B virus-infected pediatric cohort: a 10-year studyYasmine Yousef, Kathie Beland, Emmanuel Mas, et al.
Seminars in Hematology|December 1, 2020
Genetic and epigenetic modification of human primary NK cells for enhanced antitumor activityMeisam Naeimi Kararoudi, Brian P Tullius, Nitin Chakravarti, et al.
Hepatology (Baltimore, Md.)|July 18, 2015
A novel "humanized mouse" model for autoimmune hepatitis and the association of gut microbiota with liver inflammationMuhammed Yuksel, Yipeng Wang, Ningwen Tai, et al.
Pageof 1